Skip to content
Search

Latest Stories

Pfizer to axe 500 jobs as part of its cost-cutting campaign

The US drugmaker eliminated 100 jobs at one of its manufacturing plants in Ireland last week

Pharma giant, Pfizer has announced plans to cut 500 jobs at its Sandwich site in Kent, England as part of its ongoing $3.5 billion cost-cutting drive.


The company is also planning to shut its Pharmaceutical Sciences Small Molecule (PSSM) capabilities at the site, a spokesperson of the company told FiercePharma.

However, the Sandwich site will remain open and other functions will continue with “a different size," the spokesperson added.

Currently, around 940 people are employed at the site, which is the location where Pfizer scientists first discovered Viagra.

“We are proud of our heritage of breakthrough science in the UK and we will retain a scientific presence in the U.K. including at our Discovery Park location in Sandwich,” Pfizer’s spokesperson confirmed in an email to FiercePharma.

The US drugmaker announced a global “cost realignment program” in mid-October after sales of its COVID-19 Comirnaty and antiviral Paxlovid dropped rapidly.

Layoffs have happened across Pfizer ever since the company unveiled its campaign to reduce $3.5 billion in annual costs by the end of 2024.

Last week, Pfizer eliminated 100 jobs at one of its Irish manufacturing plants in Newbridge in Kildare.

Those workers were engaged in the production of its oral COVID med Paxlovid, the company confirmed at the time.

Prior to that, Pfizer had announced that it would cut roughly 200 positions at its Kalamazoo site in Michigan.

The drug maker has also confirmed plans to close its Peapack facility in New Jersey in early 2024.

"Various areas of Pfizer's global enterprise are making changes to operate more efficiently and effectively. These changes will be implemented on a rolling basis and will differ from area to area," the company spokesperson told Reuters.

The company informed the publication that it would be sharing further details on the program as part of the full-year forecast for 2024.

An earlier report by local news outlet Kent Online stated that Pfizer was planning to discontinue all lab and manufacturing work at the Sandwich site.

The move was unexpected as the company had invested 10 million pounds sterling in advanced manufacturing technology to accelerate the development of COVID-19 drugs at the plant, Kent Online reported.

Pfizer, however, did not disclose when the layoffs at the Sandwich site will go into effect.

Meanwhile, more layoffs are expected in the coming weeks and months as Pfizer, which employs roughly 83,000 people globally, continues its cost-reduction program.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less